1 Thirteen UK pharmaceutical companies have provided comprehensive toxicological data from repeated-dose animal safety evaluation studies of 74 pharmaceutical compounds.
2 These data comprise a unique toxicology database and this paper describes its establishment including the problems encountered, its current size with over 35 000 data fields, its content and potential value for retrospective analyses.
3 Increasing reliance on animal studies for predicting the safety of medicines in man necessitates a reappraisal of conventional animal testing procedures and better use of the considerable volume of data in the archives of regulatory authorities and pharmaceutical companies. This reappraisal may be achieved by the use of computer-based toxicology databanks.
Get full access to this article
View all access options for this article.
References
1.
Alder, S., Danton, C. & Zbinden, G. (1981). Pre-clinical Safety Requirements in 1980. Swiss Federal Institute of Technology and University of Zurich .
2.
Bein, H.D. (1963). Rational and irrational numbers in toxicology . Proc. Eur. Soc. Study Drug Tox., 2, 15-24.
3.
Berti, T. & Velo, G.P. (1979). Risk-Benefit Evaluation. In Drug Assessment: Criteria and Methods, eds J. Z. Bowers & G. P. Velo, pp. 219-227. Amsterdam : Elsevier/North-Holland Biomedical Press.
4.
Cahn, J. (1983). Forecasting of cardiac side effects: vincamine and calcium antagonists, a comparative study in animals and man. In Current Problems in Drug Toxicology. Proc. Int. Symp. 'Present Problems and Future Trends in Drug Toxicology', Paris, 1983, eds G. Zbinden et al., pp. 90-94. London : John Libbey and Co.
5.
Cockburn, A. (1983). The need for flexibility. In Animals and Alternatives in Toxicity Testing. Proc. of a meeting held at the Royal Society of London, November 1982, to discuss the report of the FRAME Toxicity Committee, eds M. Balls, R. J. Riddell & A. N. Worden, pp. 457-461. London: Academic Press.
6.
Conning, D.M. (1983). Regulations - General discussion. In Animals and Alternatives in Toxicity Testing. Proc. of a meeting held at the Royal Society of London, November 1982 to discuss the report of the FRAME Toxicity Committee, eds M. Balls , R. J. Riddell & A. N. Worden, pp. 467-469. London: Academic Press.
7.
Cuthbert, M.F. (1974). Adverse reactions to non-steroidal antirheumatic drugs. Curr. Med. Res. Opin., 2, 600-609.
8.
D'Aguanno, W. (1973). Drug-toxicity evaluation - pre-clinical aspects. FDA Introduction to Total Drug Quality. DHEW Publication No. (FDA) 74-30006, pp. 35-40.
9.
De Schaepdryver, A.F. (1978). Toxicology: general and special toxicity testing. A situation paper. In The Scientific Basis of Official Regulation of Drug Research and Development, eds A. F. DE Schaepdryver et al., pp. 25-27. Ghent: Heymans Foundation.
10.
Drury, V.W.M., Wade, O.L., Beeley, L. & Alesbury, P. (1983) Treatment: a Handbook of Drug Therapy. London: Kluwer Medical.
11.
Fletcher, A.P. (1978). Drug safety tests and subsequent clinical experience . J. R. Soc. Med., 71,693-696.
12.
Gelzer, J. (1979). Government toxicology regulations: an encumbrance to drug research. Arch. Toxicol., 43, 19-26.
13.
Hanley, T., Udall, V. & Weatherall, M. (1970). An industrial view of current practice in predicting drug toxicity. Br. Med. Bull. , 26(3), 203-207.
14.
Homburger, F. (1983). Introduction to method development session. In Safety Evaluation and Regulation of chemicals. First Int. Conf, Boston, Massachusetts, 1982 , ed. F. Homburger, pp. 191-192. Basle : Karger.
15.
Hpb (1981). Pre-clinical Toxicologic Guidelines. Bureau of Human Prescription Drugs, Health Protection Branch, Health and Welfare Canada.
16.
Kesterson, J.W. (1982). Drug safety evaluation: animal toxicology studies and their interpretations. Drug Inform. J., January/June, 22-34.
17.
Klaasen, C.D. & Doull, J. (1980). Evaluation of safety: toxicologic evaluation. In Casarett and Doull's Toxicology: the Basic Science of Poisons, 2nd edn, eds J. Doull, C. D. Klaasen & M. O. Amdur, pp. 11-27. New York: Macmillan Publishing Co.
18.
Litchfield, J.T. (1961). Forecasting drug effects in man from studies in laboratory animals. J. Am. Med. Assoc., 177, 104-108.
19.
Lumley, C.E. & Walker, S.R. (1985a). The establishment of a computer-based toxicology databank. Med. Inform., in press.
20.
Lumley, C.E. & Walker, S.R. (1985b). What is the value of animal toxicology studies beyond 6 Months? Br. J. Pharmac., Proceeding84, 117 P.
21.
McNamara, B.P. (1976). Concepts in health evaluation of commercial and industrial chemicals. In New Concepts in Safety Evaluation , eds M. A. Mehlman, R. E. Shapiro & H. Blumenthal , pp. 61-115. New York: John Wiley and Sons.
22.
McNamara, B.P. (1979). Concepts and methodology for toxicological testing . ACS Symp. Ser., 96, 215-236.
23.
Page, N.P. (1977). Chronic toxicity and carcinogenicity guidelines . J. Environ. Pathol. Toxicol., 1, 161-182.
24.
Peck, H.M. (1968). An appraisal of drug safety evaluation in animals and the extrapolation of results to man. In Importance of Fundamental Principles in Drug Evaluation, eds D. H. Tedeschi & R. E. Tedeschi, pp. 449-471. New York: Raven Press.
25.
Rodricks, J.V. & Tardiff, R.G. (1983). Biological basis for risk assessment. In Safety Evaluation and Regulation of Chemicals. First Int. Conf, Boston, Massachusetts, 1982, ed. F. Homburger, pp. 77-84. Basle : Karger.
26.
Suter, K.E. (1983). Relevance of standard toxicological tests. Comparison of the experimental and clinical data of six pharmaceutical preparations. In Current Problems in Drug Toxicology. Proc. Int. Symp. 'Present Problems and Future Trends in Drug Toxicology', Paris, 1983, eds. G. Zbinden et al., pp. 72-76. London: John Libbey and Co.
27.
Tattersall, M.L. (1983). Acute toxicity testing with small numbers of animals . In Current Problems in Drug Toxicology, Proc. Int. Symp. 'Present Problems and Future Trends in Drug Toxicology', Paris, 1983, eds G. Zbinden et al., pp. 120-125. London: John Libbey and Co.
28.
Weil, C.S. & McCollister, D.D. (1963). Safety evaluation of chemicals. Relationship between short and long-term feeding studies in designing an effective toxicity test. J. Agric. Food Chem., 11, 486-491.
29.
Zbinden, G. (1973). Toxicological pre-requisites for the study and general release of new drugs. In Progress in Toxicology, vol. 1, ed. G. Zbinden , pp. 4-27. Heidelberg: Springer-Verlag.
30.
Zbinden, G. (1979). Keynote Address: Pre-clinical Studies and Requirements. The Theoretical and Practical Relationship of Studies in Animal and Man. IFPMA Symp. on Int. Drug Registration, Geneva , 1979. Switzerland: IFPMA, pp. 6-130.
31.
Zbinden, G. (1980). Predictive Value of Pre-clinical Drug Safety Evaluation . Proc. First World Conf. on Clinical Pharmacology and Therapeutics, London, UK, 1980, eds P. Turner, C. Padgham, A. Hedges, pp. 9-14. London : Macmillan.
